Latest Oncolytic virus Stories
CALGARY, July 8, 2014 /PRNewswire/ - Oncolytics Biotech Inc.
Inhibits Tumor Growth and Vascular Progenitors for Neuroblastoma and Malignant Peripheral Nerve Sheath Tumors CINCINNATI, June 23, 2014 /PRNewswire/ -- Bacterial Robotics, a synthetic
BUSAN, South Korea and SAN FRANCISCO, June 20, 2014 /PRNewswire/ -- SillaJen, Inc., a privately-held biotherapeutics company focused on the development of targeted oncolytic immunotherapy products
Merger Creates Global Leader In Oncolytic Immunotherapy BUSAN, South Korea and SAN FRANCISCO, June 19, 2014 /PRNewswire/ -- SillaJen, Inc., a privately-held biotherapeutics company
CALGARY, June 19, 2014 /PRNewswire/ - Oncolytics Biotech Inc.
Unique Immuno-Oncolytic Therapy Gets Closer to a More Effective, Safer Cancer Treatment and Potential Cure CLEVELAND, June 18, 2014 /PRNewswire-USNewswire/ -- Western Oncolytics
Giving low doses of a particular targeted agent with a cancer-killing virus might improve the effectiveness of the virus as a treatment for cancer.
SAN DIEGO, June 17, 2014 /PRNewswire/ -- DNAtrix, Inc., experts in oncolytic virus development, today announced that the U.S.
CALGARY, June 16, 2014 /PRNewswire/ - Oncolytics Biotech Inc.
LONDON, June 10, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
- A serpent whose bite was fabled to produce intense thirst.